Paul Larson, MD

Title(s)Professor, Neurological Surgery
SchoolSchool of Medicine
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    University of Arizona, Tucson, AZ1995MD
    University of Louisville, Louisville, KY2001Neurosurgery Residency

    Collapse Overview 
    Collapse Overview
    Dr. Paul Larson is Professor and Vice Chair of Neurological Surgery at the University of California San Francisco, Chief of Neurosurgery at the San Francisco VA Medical Center and Surgical Director of the Parkinson’s Disease Research, Education and Clinical Center. He specializes in functional neurosurgery, specifically deep brain stimulation for movement disorders and MR-guided procedures. The Surgical Movement Disorders program at UCSF and the SFVA is one of the largest and most active centers in the world.

    Dr. Larson’s research program is built around three core areas of interest. He has 20 years of experience in interventional MRI-guided surgery, and was one of three researchers at UCSF that started and developed the field of iMRI-guided stereotactic surgery for DBS placement and drug delivery. He has had continuous funding for device development and clinical trials in interventional MRI procedures since 2003. Secondly, his group at UCSF has been at the forefront of gene therapy for Parkinson’s disease. They have had a leadership role in 4 of the 7 human trials completed worldwide to date, and have performed more than 1/3 of all Parkinson’s gene therapy procedures ever performed. He is currently the PI for a fifth gene therapy trial using convection enhanced, iMRI-guided delivery of AAV2-AADC into the putamen of patients with Parkinson’s disease. Finally, Dr. Larson has a significant interest in the neurobiology and underlying brain circuitry of phantom auditory disorders including tinnitus. His work in this area with Dr. Steven Cheung has led to the discovery of a new region of brain involved in auditory perception, as well as a new proposed model of the basal ganglia for chronic tinnitus. They have a U01 grant from the NIDCD to study the use of DBS in the caudate nucleus in patients with severe, medically refractory tinnitus.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Therapeutic DBS for OCD Suppresses the Default Mode Network. bioRxiv. 2024 Jul 24. Slepneva N, Basich-Pease G, Reid L, Frank AC, Norbu T, Krystal AD, Sugrue LP, Motzkin JC, Larson PS, Starr PA, Morrison MA, Lee AM. PMID: 39091832; PMCID: PMC11291060.
      View in: PubMed   Mentions:
    2. 329. Converging Evidence for Suppression of Default Mode Network in Deep Brain Stimulation for Obsessive-Compulsive Disorder. Biological Psychiatry. 2024 May 1; 95(10):s234-s235. Slepneva SN, Basich-Pease BG, Frank FA, Norbu NT, Sugrue SL, Larson LP, Starr SP, Morrison MM, Lee LA. .
      View in: Publisher Site   Mentions:
    3. AAV2-GDNF Gene Delivery in Mild- and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes. Parkinsonism & Related Disorders. 2024 May 1; 122:106134. Van Laar VA, Christine CC, Phielipp PN, Merola MA, Elder EJ, Larson LP, San Sebastian SW, Fiandaca FM, Kells KA, Bankiewicz BK. .
      View in: Publisher Site   Mentions:
    4. Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease (N2.001). Neurology. 2024 Apr 9; 102(17_supplement_1). Van Laar VA, Christine CC, Merola MA, Phielipp PN, Elder EB, Larson LP, Sebastian SW, Fiandaca FM, Kells KA, Bankiewicz BK. .
      View in: Publisher Site   Mentions:
    5. Tractography-based DBS lead repositioning improves outcome in refractory OCD and depression. Front Hum Neurosci. 2023; 17:1339340. Basich-Pease G, Slepneva N, Frank AC, Norbu T, Morrison MA, Sugrue LP, Larson PS, Starr PA, Lee AM. PMID: 38384668; PMCID: PMC10879278.
      View in: PubMed   Mentions:
    6. Procedure-Related Complications in Sham Surgeries for Parkinson's Clinical Trials: A Meta-analysis. Mov Disord. 2023 07; 38(7):1223-1235. Mamaril-Davis JC, Gelb AW, Larson PS. PMID: 37165974.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Targeting Accuracy and Clinical Outcomes of Awake versus Asleep Interventional Magnetic Resonance Imaging-Guided Deep Brain Stimulation for Parkinson's Disease: The University of California, San Francisco Experience. Neurosurgery. 2022 11 01; 91(5):717-725. Lee AT, Han KJ, Nichols N, Sudhakar VR, Burke JF, Wozny TA, Chung JE, Volz MM, Ostrem JL, Martin AJ, Larson PS, Starr PA, Wang DD. PMID: 36069560.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology. 2022 08 09; 99(6):259. Christine CW, Richardson RM, Fine EM, Khwaja OS, Liang GS, Meier A, Roberts EW, Bankiewicz K, Larson PS. PMID: 35940891.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology. 2022 08 09; 99(6):260-261. Christine CW, Richardson RM, Van Laar A, Fine EM, Khwaja OS, Liang GS, Bankiewicz K, Larson PS. PMID: 35940892.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Benefits and Risks of a Staged-Bilateral VIM Versus Unilateral VIM DBS for Essential Tremor. Mov Disord Clin Pract. 2022 Aug; 9(6):775-784. Prakash P, Deuschl G, Ozinga S, Mitchell KT, Cheeran B, Larson PS, Merola A, Groppa S, Tomlinson T, Ostrem JL. PMID: 35937489; PMCID: PMC9346253.
      View in: PubMed   Mentions: 4     Fields:    
    11. Reduced Risk of Reoperations With Modern Deep Brain Stimulator Systems: Big Data Analysis From a United States Claims Database. Front Neurol. 2021; 12:785280. Wu C, Nagel SJ, Agarwal R, Pötter-Nerger M, Hamel W, Sharan AD, Connolly AT, Cheeran B, Larson PS. PMID: 34925219; PMCID: PMC8675885.
      View in: PubMed   Mentions: 3  
    12. Identification of a Personalized Intracranial Biomarker of Depression and Response to DBS Therapy. Brain Stimulation. 2021 Nov 1; 14(6):1591. Frank FA, Scangos SK, Larson LP, Norbu NT, Lee LA, Lee LM. .
      View in: Publisher Site   Mentions:
    13. Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology. 2022 01 04; 98(1):e40-e50. Christine CW, Richardson RM, Van Laar AD, Thompson ME, Fine EM, Khwaja OS, Li C, Liang GS, Meier A, Roberts EW, Pfau ML, Rodman JR, Bankiewicz KS, Larson PS. PMID: 34649873; PMCID: PMC8726573.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    14. Striatal networks for tinnitus treatment targeting. Hum Brain Mapp. 2022 02 01; 43(2):633-646. Hinkley LBN, Larson PS, Henderson Sabes J, Mizuiri D, Demopoulos C, Adams ME, Neylan TC, Hess CP, Nagarajan SS, Cheung SW. PMID: 34609038; PMCID: PMC8720198.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Identification of a personalized intracranial biomarker of depression and response to DBS therapy. Brain Stimul. 2021 Jul-Aug; 14(4):1002-1004. Frank AC, Scangos KW, Larson PS, Norbu T, Lee AT, Lee AM. PMID: 34175247; PMCID: PMC8880609.
      View in: PubMed   Mentions: 7     Fields:    
    16. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease. Nat Biotechnol. 2021 09; 39(9):1078-1085. Gilron R, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS, Racine CA, Wang SS, Ostrem JL, Larson PS, Wang DD, Galifianakis NB, Bledsoe IO, San Luciano M, Dawes HE, Worrell GA, Kremen V, Borton DA, Denison T, Starr PA. PMID: 33941932; PMCID: PMC8434942.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    17. Are preoperative chlorhexidine gluconate showers associated with a reduction in surgical site infection following craniotomy? A retrospective cohort analysis of 3126 surgical procedures. J Neurosurg. 2021 12 01; 135(6):1889-1897. Ammanuel SG, Edwards CS, Chan AK, Mummaneni PV, Kidane J, Vargas E, D'Souza S, Nichols AD, Sankaran S, Abla AA, Aghi MK, Chang EF, Hervey-Jumper SL, Kunwar S, Larson PS, Lawton MT, Starr PA, Theodosopoulos PV, Berger MS, McDermott MW. PMID: 33930864; PMCID: PMC9448162.
      View in: PubMed   Mentions:    Fields:    
    18. Impact of brain shift on neural pathways in deep brain stimulation: a preliminary analysis via multi-physics finite element models. J Neural Eng. 2021 04 06; 18(5). Luo M, Narasimhan S, Larson PS, Martin AJ, Konrad PE, Miga MI. PMID: 33740780; PMCID: PMC9476060.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. CT and MRI Image Fusion Error: An Analysis of Co-Registration Error Using Commercially Available Deep Brain Stimulation Surgical Planning Software. Stereotact Funct Neurosurg. 2021; 99(3):196-202. Burke JF, Tanzillo D, Starr PA, Lim DA, Larson PS. PMID: 33535219.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Improved Delivery Methods for Gene Therapy and Cell Transplantation in Parkinson's Disease. J Parkinsons Dis. 2021; 11(s2):S199-S206. Larson PS. PMID: 34366372; PMCID: PMC8543258.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Preoperative Chlorhexidine Showers Are Not Associated With a Reduction in Surgical Site Infection Following Craniotomy. Neurosurgery. 2020 Dec 1; 67(Supplement_1). Ammanuel AS, Edwards EC, Chan CA, Mummaneni MP, Kidane KJ, Vargas VE, D’Souza DS, Nichols NA, Sankaran SS, Abla AA, Aghi AM, Chang CE, Her vey-Jumper HS, Kunwar KS, Larson LP, Lawton LM, Starr SP, Theodosopoulos TP, Berger BM, McDermott MM. .
      View in: Publisher Site   Mentions:
    22. Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2020 11; 91(11):1210-1218. Richardson RM, Bankiewicz KS, Christine CW, Van Laar AD, Gross RE, Lonser R, Factor SA, Kostyk SK, Kells AP, Ravina B, Larson PS. PMID: 32732384; PMCID: PMC7569395.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    23. Rescue Ventral Intermediate Thalamus Deep Brain Stimulation to Address Refractory Tremor Following Subthalamic Nucleus Deep Brain Stimulation With Brittle Dyskinesia. . 2020 Jun 1; 115-118. Afshari AM, Ostrem OJ, Luciano LM, Larson LP. .
      View in: Publisher Site   Mentions:
    24. Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease. Mov Disord. 2020 05; 35(5):851-858. Nutt JG, Curtze C, Hiller A, Anderson S, Larson PS, Van Laar AD, Richardson RM, Thompson ME, Sedkov A, Leinonen M, Ravina B, Bankiewicz KS, Christine CW. PMID: 32149427; PMCID: PMC7318280.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    25. Prefrontal-Subthalamic Hyperdirect Pathway Modulates Movement Inhibition in Humans. Neuron. 2020 05 20; 106(4):579-588.e3. Chen W, de Hemptinne C, Miller AM, Leibbrand M, Little SJ, Lim DA, Larson PS, Starr PA. PMID: 32155442; PMCID: PMC7274135.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    26. Accounting for Deformation in Deep Brain Stimulation Surgery With Models: Comparison to Interventional Magnetic Resonance Imaging. IEEE Trans Biomed Eng. 2020 10; 67(10):2934-2944. Luo M, Larson PS, Martin AJ, Miga MI. PMID: 32078527; PMCID: PMC9476051.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Phase I trial of caudate deep brain stimulation for treatment-resistant tinnitus. J Neurosurg. 2020 10 01; 133(4):992-1001. Cheung SW, Racine CA, Henderson-Sabes J, Demopoulos C, Molinaro AM, Heath S, Nagarajan SS, Bourne AL, Rietcheck JE, Wang SS, Larson PS. PMID: 31553940; PMCID: PMC7089839.
      View in: PubMed   Mentions: 10     Fields:    
    28. Altered Prefrontal Theta and Gamma Activity during an Emotional Face Processing Task in Parkinson Disease. J Cogn Neurosci. 2019 11; 31(11):1768-1776. Chen W, de Hemptinne C, Leibbrand M, Miller AM, Larson PS, Starr PA. PMID: 31322465.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. PD-1102: A Phase 1 study of VY-AADC01 Administered Using a Posterior Approach in Patients with Parkinson’s Disease and Motor Fluctuations (P1.8-017). Neurology. 2019 Apr 9; 92(15_supplement). Van Laar VA, Richardson RM, Christine CC, Factor FS, Gross GR, Kostyk KS, Lonser LR, de Somer dM, Sedkov SA, Ravina RB, Kells KA, Bankiewicz BK, Larson LP. .
      View in: Publisher Site   Mentions:
    30. Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease. Ann Neurol. 2019 05; 85(5):704-714. Christine CW, Bankiewicz KS, Van Laar AD, Richardson RM, Ravina B, Kells AP, Boot B, Martin AJ, Nutt J, Thompson ME, Larson PS. PMID: 30802998; PMCID: PMC6593762.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    31. Human caudate nucleus subdivisions in tinnitus modulation. J Neurosurg. 2020 03 01; 132(3):705-711. Perez PL, Wang SS, Heath S, Henderson-Sabes J, Mizuiri D, Hinkley LB, Nagarajan SS, Larson PS, Cheung SW. PMID: 30738400; PMCID: PMC6687562.
      View in: PubMed   Mentions: 10     Fields:    
    32. Chapter 23 Direct Convective Nervous System Drug Delivery for Patients with Neurodegenerative Disorders. Nervous System Drug Delivery. 2019 Jan 1; 463-472. Richardson RR, Larson LP. .
      View in: Publisher Site   Mentions:
    33. An Integrated Multi-physics Finite Element Modeling Framework for Deep Brain Stimulation: Preliminary Study on Impact of Brain Shift on Neuronal Pathways. . 2019 Jan 1; 11768:682-690. Luo LM, Larson LP, Martin MA, Konrad KP, Miga MM. .
      View in: Publisher Site   Mentions:
    34. Surgical management of camptocormia in Parkinson's disease: systematic review and meta-analysis. J Neurosurg. 2019 08 01; 131(2):368-375. Chan AK, Chan AY, Lau D, Durcanova B, Miller CA, Larson PS, Starr PA, Mummaneni PV. PMID: 30215560.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    35. Accuracy of image-guided percutaneous injection into a phantom spinal cord utilizing flat panel detector CT with MR fusion and integrated navigational software. J Neurointerv Surg. 2018 Dec; 10(12):e37. Talbott JF, Cooke DL, Mabray MC, Larson PS, Amans MR, Hetts SW, Wilson MW, Moore T, Salegio EA. PMID: 29666181.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    36. Unilateral Versus Bilateral Ventral Intermediate Nucleus Deep Brain Stimulation for Axial Essential Tremor Symptoms (S18.003). Neurology. 2018 Apr 10; 90(15_supplement). Mitchell MK, Peichel PD, Wharen WR, Okun OM, Guthrie GB, Uitti UR, Larson LP, Walker WH, Pahwa PR, Dashtipour DK, Jankovic JJ, Foote FK, Schwalb SJ, Ford FB, Simpson SR, Phibbs PF, Neimat NJ, Stewart SR, Marshall MF, Ostrem OJ. .
      View in: Publisher Site   Mentions:
    37. Venous Thromboembolism during Interventional MRI-Guided Stereotactic Surgery. Stereotact Funct Neurosurg. 2018; 96(1):40-45. Kundishora AJ, Englot DJ, Starr PA, Martin AJ, Larson PS. PMID: 29495014; PMCID: PMC5949870.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Laser ablative therapy of sessile hypothalamic hamartomas in children using interventional MRI: report of 5 cases. J Neurosurg Pediatr. 2018 05; 21(5):460-465. Southwell DG, Birk HS, Larson PS, Starr PA, Sugrue LP, Auguste KI. PMID: 29451455.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Deep Brain Stimulation: Interventional and Intraoperative MRI Approaches. Prog Neurol Surg. 2018; 33:187-197. Larson PS, Starr PA, Martin AJ. PMID: 29332083.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Before and after the veterans affairs cooperative program 468 study: Deep brain stimulator target selection for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2018 03; 48:40-44. Southwell DG, Rutkowski MJ, San Luciano M, Racine C, Ostrem J, Starr PA, Larson PS. PMID: 29249683.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Hemorrhage Detection and Incidence during Magnetic Resonance-Guided Deep Brain Stimulator Implantations. Stereotact Funct Neurosurg. 2017; 95(5):307-314. Martin AJ, Starr PA, Ostrem JL, Larson PS. PMID: 28889128.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Little Black Boxes: Noncardiac Implantable Electronic Medical Devices and Their Anesthetic and Surgical Implications. Anesth Analg. 2017 07; 125(1):124-138. Srejic U, Larson P, Bickler PE. PMID: 28489640.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. MRI-guided stereotactic neurosurgical procedures in a diagnostic MRI suite: Background and safe practice recommendations. J Healthc Risk Manag. 2017 Jul; 37(1):31-39. Larson PS, Willie JT, Vadivelu S, Azmi-Ghadimi H, Nichols A, Fauerbach LL, Johnson HB, Graham D. PMID: 28719087.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    44. Parkinson's disease patient preference and experience with various methods of DBS lead placement. Parkinsonism Relat Disord. 2017 Aug; 41:25-30. LaHue SC, Ostrem JL, Galifianakis NB, San Luciano M, Ziman N, Wang S, Racine CA, Starr PA, Larson PS, Katz M. PMID: 28615151.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    45. Neurosurgical laser ablation and MR thermometry: Risks of multisite workflow pattern. J Healthc Risk Manag. 2017 Apr; 36(4):7-18. Larson PS, Vadivelu S, Azmi-Ghadimi H, Nichols A, Fauerbach L, Johnson HB. PMID: 28415147.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial. Parkinsonism Relat Disord. 2017 Jul; 40:18-26. Wharen RE, Okun MS, Guthrie BL, Uitti RJ, Larson P, Foote K, Walker H, Marshall FJ, Schwalb J, Ford B, Jankovic J, Simpson R, Dashtipour K, Phibbs F, Neimat JS, Stewart RM, Peichel D, Pahwa R, Ostrem JL, SJM DBS ET Study Group. PMID: 28400200.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    47. Little Black Boxes. Survey of Anesthesiology. 2017 Jan 1; 61(5-6):121. Srejic SU, Larson LP, Bickler BP. .
      View in: Publisher Site   Mentions:
    48. An unexpectedly high rate of revisions and removals in deep brain stimulation surgery: Analysis of multiple databases. Parkinsonism Relat Disord. 2016 12; 33:72-77. Rolston JD, Englot DJ, Starr PA, Larson PS. PMID: 27645504; PMCID: PMC5240785.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    49. Spinal Subdural Abscess Following Laminectomy for Symptomatic Stenosis: A Report of 2 Cases and Review of the Literature. Am J Case Rep. 2016 Jul 12; 17:476-83. Ramos AD, Rolston JD, Gauger GE, Larson PS. PMID: 27402228; PMCID: PMC4944552.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system. Expert Rev Neurother. 2016 06; 16(6):635-9. Han SJ, Bankiewicz K, Butowski NA, Larson PS, Aghi MK. PMID: 27054877; PMCID: PMC5553275.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. Comparison of Deep Brain Stimulation Lead Targeting Accuracy and Procedure Duration between 1.5- and 3-Tesla Interventional Magnetic Resonance Imaging Systems: An Initial 12-Month Experience. Stereotact Funct Neurosurg. 2016; 94(2):102-7. Southwell DG, Narvid JA, Martin AJ, Qasim SE, Starr PA, Larson PS. PMID: 27093443.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    52. Deep brain stimulator implantation in a diagnostic MRI suite: infection history over a 10-year period. J Neurosurg. 2017 Jan; 126(1):108-113. Martin AJ, Larson PS, Ziman N, Levesque N, Volz M, Ostrem JL, Starr PA. PMID: 27015399.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    53. Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer. Hum Gene Ther. 2016 07; 27(7):522-7. Marks WJ, Baumann TL, Bartus RT. PMID: 26711317.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    54. Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease. Mol Ther Methods Clin Dev. 2016; 3:15051. Rowland NC, Kalia SK, Kalia LV, Larson PS, Lim DA, Bankiewicz KS. PMID: 26817024; PMCID: PMC4714520.
      View in: PubMed   Mentions: 4  
    55. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. J Neurosurg. 2016 Apr; 124(4):908-16. Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, Racine CA, Martin AJ, Markun LC, Larson PS. PMID: 26495947.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    56. E-053 accuracy of flat panel detector ct with integrated navigational software with and without mr fusion for single pass needle placement in a deep brain stimulator phantom in the interventional suite. Journal of NeuroInterventional Surgery. 2015 Jul 1; 7(Suppl 1):a66.1-a66. Mabray MM, Datta DS, Lillaney LP, Moore MT, Gehrisch GS, Talbott TJ, Larson LP, Cooke CD. .
      View in: Publisher Site   Mentions:
    57. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Ann Neurol. 2015 Aug; 78(2):248-57. Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, Henderson JM, Stern M, Baltuch G, Goetz CG, Herzog C, Kordower JH, Alterman R, Lozano AM, Lang AE. PMID: 26061140.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCells
    58. Accuracy of flat panel detector CT with integrated navigational software with and without MR fusion for single-pass needle placement. J Neurointerv Surg. 2016 Jul; 8(7):731-5. Mabray MC, Datta S, Lillaney PV, Moore T, Gehrisch S, Talbott JF, Levitt MR, Ghodke BV, Larson PS, Cooke DL. PMID: 26047903; PMCID: PMC5380922.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Parkinson’s Disease (PD) Patient Experience with the ClearPoint(TM) Interventional MRI (iMRI)-Guided Method for Placement of Deep Brain Stimulation (DBS) Leads (P6.085). Neurology. 2015 Apr 6; 84(14_supplement). LaHue LS, Katz KM, Galifianakis GN, San Luciano SM, Ziman ZN, Wang WS, Racine RC, Starr SP, Larson LP, Ostrem OJ. .
      View in: Publisher Site   Mentions:
    60. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Ann Neurol. 2015 Apr; 77(4):710-9. Katz M, Luciano MS, Carlson K, Luo P, Marks WJ, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL, CSP 468 study group. PMID: 25627340.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    61. Surgical implantation of STN-DBS leads using intraoperative MRI guidance: technique, accuracy, and clinical benefit at 1-year follow-up. Acta Neurochir (Wien). 2015 Apr; 157(4):729-37. Chabardes S, Isnard S, Castrioto A, Oddoux M, Fraix V, Carlucci L, Payen JF, Krainik A, Krack P, Larson P, Le Bas JF. PMID: 25788414.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    62. Combining cell transplants or gene therapy with deep brain stimulation for Parkinson's disease. Mov Disord. 2015 Feb; 30(2):190-5. Rowland NC, Starr PA, Larson PS, Ostrem JL, Marks WJ, Lim DA. PMID: 25521796.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    63. Delay Period Activity of the Substantia Nigra during Proactive Control of Response Selection as Determined by a Novel fMRI Localization Method. J Cogn Neurosci. 2015 Jun; 27(6):1238-48. Yoon JH, Larson P, Grandelis A, La C, Cui E, Carter CS, Minzenberg MJ. PMID: 25514657.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9. Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D, CSP-468 Study Group. PMID: 25185211.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    65. Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deployment. Mol Ther. 2015 Jan; 23(1):119-29. Silvestrini MT, Yin D, Martin AJ, Coppes VG, Mann P, Larson PS, Starr PA, Zeng X, Gupta N, Panter SS, Desai TA, Lim DA. PMID: 25138755; PMCID: PMC4426791.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    66. Interventional MRI-guided deep brain stimulation in pediatric dystonia: first experience with the ClearPoint system. J Neurosurg Pediatr. 2014 Oct; 14(4):400-8. Starr PA, Markun LC, Larson PS, Volz MM, Martin AJ, Ostrem JL. PMID: 25084088.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    67. Deep brain stimulation for movement disorders. Neurotherapeutics. 2014 Jul; 11(3):465-74. Larson PS. PMID: 24833244; PMCID: PMC4121453.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    68. Brain shift during bur hole-based procedures using interventional MRI. J Neurosurg. 2014 Jul; 121(1):149-60. Ivan ME, Yarlagadda J, Saxena AP, Martin AJ, Starr PA, Sootsman WK, Larson PS. PMID: 24785326.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    69. Image-guided deep brain stimulation. Neurosurg Clin N Am. 2014 Jan; 25(1):159-72. Vega RA, Holloway KL, Larson PS. PMID: 24262907.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    70. 203 Application Accuracy of a Second Generation Interventional MRI Stereotactic Platform. Neurosurgery. 2013 Aug 1; 60(&NA;):187. Larson LP, Starr SP, Ostrem OJ, Galifianakis GN, San Luciano Palenzuela SM, Martin MA. .
      View in: Publisher Site   Mentions:
    71. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. J Neurol Neurosurg Psychiatry. 2013 Oct; 84(10):1113-8. Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, Stern M, Follett KA, Reda D, Weaver FM, CSP 468 Study Group. PMID: 23667214; PMCID: PMC4594869.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    72. Responsiveness of Parkinson's Disease Motor Subtypes to Subthalamic Nucleus (STN) Versus Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS): An Additional Analysis of the VA CSP #468 Study (S23.006). Neurology. 2013 Feb 12; 80(7_supplement). Katz KM, San Luciano SM, Luo LP, Carlson CK, Marks MW, Larson LP, Starr SP, Follett FK, Weaver WF, Stern SM, Reda RD, Ostrem OJ. .
      View in: Publisher Site   Mentions:
    73. Radially branched deployment for more efficient cell transplantation at the scale of the human brain. Stereotact Funct Neurosurg. 2013; 91(2):92-103. Silvestrini MT, Yin D, Coppes VG, Mann P, Martin AJ, Larson PS, Starr PA, Gupta N, Panter SS, Desai TA, Lim DA. PMID: 23343609; PMCID: PMC3739996.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    74. A stroke of silence: tinnitus suppression following placement of a deep brain stimulation electrode with infarction in area LC. J Neurosurg. 2013 Jan; 118(1):192-4. Larson PS, Cheung SW. PMID: 23082889.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    75. Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg. 2013 Jun; 115(6):708-12. Ostrem JL, Galifianakis NB, Markun LC, Grace JK, Martin AJ, Starr PA, Larson PS. PMID: 22944465; PMCID: PMC3578021.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    76. Securing dual ipsilateral leads through a single burr hole in deep brain stimulation surgery: technical note. Stereotact Funct Neurosurg. 2012; 90(6):361-4. Potts MB, Larson PS. PMID: 22922401.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 2012 Jul 03; 79(1):55-65. Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ, CSP 468 Study Group. PMID: 22722632; PMCID: PMC3385495.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    78. Acute effects of thalamic deep brain stimulation and thalamotomy on sensorimotor cortex local field potentials in essential tremor. Clin Neurophysiol. 2012 Nov; 123(11):2232-8. Air EL, Ryapolova-Webb E, de Hemptinne C, Ostrem JL, Galifianakis NB, Larson PS, Chang EF, Starr PA. PMID: 22633916; PMCID: PMC3577937.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    79. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum Gene Ther. 2012 Apr; 23(4):377-81. Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS. PMID: 22424171; PMCID: PMC4530392.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCellsCTClinical Trials
    80. An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: preliminary evaluation of targeting accuracy. Neurosurgery. 2012 Mar; 70(1 Suppl Operative):95-103; discussion 103. Larson PS, Starr PA, Bates G, Tansey L, Richardson RM, Martin AJ. PMID: 21796000; PMCID: PMC3249469.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    81. Deep brain stimulation in area LC controllably triggers auditory phantom percepts. Neurosurgery. 2012 Feb; 70(2):398-405; discussion 405-6. Larson PS, Cheung SW. PMID: 21849922.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    82. Abnormal T2-weighted MRI signal surrounding leads in a subset of deep brain stimulation patients. Stereotact Funct Neurosurg. 2011; 89(5):311-7. Englot DJ, Glastonbury CM, Larson PS. PMID: 21894061.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    83. Lead cap localization using ultrasound in deep brain stimulation surgery: technical note. Minim Invasive Neurosurg. 2011 Feb; 54(1):48-9. Englot DJ, Chang EF, Larson PS. PMID: 21506069.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    84. Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg. 2011; 89(3):141-51. Richardson RM, Kells AP, Martin AJ, Larson PS, Starr PA, Piferi PG, Bates G, Tansey L, Rosenbluth KH, Bringas JR, Berger MS, Bankiewicz KS. PMID: 21494065; PMCID: PMC3085040.
      View in: PubMed   Mentions: 45     Fields:    Translation:Animals
    85. Intraoperative computed tomography for deep brain stimulation surgery: technique and accuracy assessment. Neurosurgery. 2011 Mar; 68(1 Suppl Operative):114-24; discussion 124. Shahlaie K, Larson PS, Starr PA. PMID: 21206322.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    86. Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol Ther. 2011 Jun; 19(6):1048-57. Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, Larson PS, Starr PA, Martin AJ, Lonser RR, Federoff HJ, Forsayeth JR, Bankiewicz KS. PMID: 21343917; PMCID: PMC3129792.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    87. Incidence and management of venous air embolisms during awake deep brain stimulation surgery in a large clinical series. Stereotact Funct Neurosurg. 2011; 89(2):76-82. Chang EF, Cheng JS, Richardson RM, Lee C, Starr PA, Larson PS. PMID: 21293166.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    88. Chapter 18 Safety Concerns and Limitations. Essential Neuromodulation. 2011 Jan 1; 397-412. Larson LP, Martin MA, Rezai RA, Arle AJ. .
      View in: Publisher Site   Mentions:
    89. Human/nonhuman primate AC-PC ratio--considerations for translational brain measurements. J Neurosci Methods. 2011 Mar 15; 196(1):124-30. Fiandaca MS, Salegio EA, Yin D, Richardson RM, Valles FE, Larson PS, Starr PA, Lonser RR, Bankiewicz KS. PMID: 21185868; PMCID: PMC3042049.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    90. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery. 2010 Nov; 67(5):1377-85. Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, Christine CW, Forsayeth J, Richardson RM, Su X, Aminoff MJ, Bankiewicz KS. PMID: 20871425.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCellsCTClinical Trials
    91. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Dec; 9(12):1164-1172. Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW. PMID: 20970382.
      View in: PubMed   Mentions: 268     Fields:    Translation:HumansCellsCTClinical Trials
    92. Minimally invasive surgery for movement disorders. Neurosurg Clin N Am. 2010 Oct; 21(4):691-8, vii. Larson PS. PMID: 20947036.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    93. Tinnitus modulation by deep brain stimulation in locus of caudate neurons (area LC). Neuroscience. 2010 Sep 15; 169(4):1768-78. Cheung SW, Larson PS. PMID: 20541595.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    94. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010 Jun 03; 362(22):2077-91. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ, CSP 468 Study Group. PMID: 20519680.
      View in: PubMed   Mentions: 409     Fields:    Translation:Humans
    95. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg. 2010 Mar; 112(3):479-90. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS. PMID: 19681683; PMCID: PMC2866526.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    96. Physiological identification of the human pedunculopontine nucleus. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):80-6. Shimamoto SA, Larson PS, Ostrem JL, Glass GA, Turner RS, Starr PA. PMID: 19828478; PMCID: PMC3806635.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    97. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. 2009 Nov 17; 73(20):1662-9. Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ. PMID: 19828868; PMCID: PMC2839805.
      View in: PubMed   Mentions: 184     Fields:    Translation:HumansCTClinical Trials
    98. Software requirements for interventional MR in restorative and functional neurosurgery. Neurosurg Clin N Am. 2009 Apr; 20(2):179-86. Martin AJ, Starr PA, Larson PS. PMID: 19555880.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    99. Intraoperative MRI in functional neurosurgery. Preface. Neurosurg Clin N Am. 2009 Apr; 20(2):xi. Lim DA, Larson PS. PMID: 19555874.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    100. Implantation of deep brain stimulator electrodes using interventional MRI. Neurosurg Clin N Am. 2009 Apr; 20(2):193-203. Starr PA, Martin AJ, Larson PS. PMID: 19555882.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    101. Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. Parkinsonism Relat Disord. 2009 Sep; 15(8):610-3. Glass GA, Ku S, Ostrem JL, Heath S, Larson PS. PMID: 19250855.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    102. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009 Jan 07; 301(1):63-73. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD, CSP 468 Study Group. PMID: 19126811; PMCID: PMC2814800.
      View in: PubMed   Mentions: 454     Fields:    Translation:Humans
    103. Interventional magnetic resonance guidance of deep brain stimulator implantation for Parkinson disease. Top Magn Reson Imaging. 2009 Jan; 19(4):213-21. Martin AJ, Larson PS, Ostrem JL, Starr PA. PMID: 19148038.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    104. Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models. Neurosurgery. 2008 Oct; 63(4):629-442; dicussion 642-4. Richardson RM, Larson PS, Bankiewicz KS. PMID: 18981876.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    105. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology. 2008 May 20; 70(21):1980-3. Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ. PMID: 18401019.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansCTClinical Trials
    106. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 2008 May; 7(5):400-8. Marks WJ, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT. PMID: 18387850.
      View in: PubMed   Mentions: 222     Fields:    Translation:HumansCellsCTClinical Trials
    107. Minimally invasive precision brain access using prospective stereotaxy and a trajectory guide. J Magn Reson Imaging. 2008 Apr; 27(4):737-43. Martin AJ, Hall WA, Roark C, Starr PA, Larson PS, Truwit CL. PMID: 18383266.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    108. Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery. 2008 Feb; 62(2):360-6; discussion 366-7. Sillay KA, Larson PS, Starr PA. PMID: 18382313.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    109. Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery. 2008 Feb; 62 Suppl 2:884-94. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA. PMID: 18596419.
      View in: PubMed   Mentions: 15     Fields:    
    110. Deep brain stimulation for psychiatric disorders. Neurotherapeutics. 2008 Jan; 5(1):50-8. Larson PS. PMID: 18164483; PMCID: PMC5084126.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    111. Technical Alternatives in Performing Deep Brain Stimulator Implantation. Deep Brain Stimulation in Neurological and Psychiatric Disorders. 2008 Jan 1; 99-110. Larson LP. .
      View in: Publisher Site   Mentions:
    112. Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series. Stereotact Funct Neurosurg. 2008; 86(2):92-100. Larson PS, Richardson RM, Starr PA, Martin AJ. PMID: 18073522.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    113. Placement of Subthalamic DBS Electrodes in a Radiology Suite Using Interventional MRI. Proceedings of the Medtronic Forum for Neuroscience and Neuro-Technology 2005. 2007 Jan 1; 37-39. Starr SP, Martin MA, Talke TP, Ostrem OJ, Sootsman SW, Levesque LN, Meyers MJ, Larson LP. .
      View in: Publisher Site   Mentions:
    114. Placement of deep brain stimulator electrodes using real-time high-field interventional magnetic resonance imaging. Magn Reson Med. 2005 Nov; 54(5):1107-14. Martin AJ, Larson PS, Ostrem JL, Keith Sootsman W, Talke P, Weber OM, Levesque N, Myers J, Starr PA. PMID: 16206144.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    115. Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery. 2004 May; 54(5):1120-29; discussion 1129-30. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA. PMID: 15113466.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    116. Frameless stereotactic neurosurgery using intraoperative magnetic resonance imaging: stereotactic brain biopsy. Neurosurgery. 2000 Nov; 47(5):1138-45; discussion 1145-6. Moriarty TM, Quinones-Hinojosa A, Larson PS, Alexander E, Gleason PL, Schwartz RB, Jolesz FA, Black PM. PMID: 11063107.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    117. Traumatic intracranial aneurysms. Neurosurg Focus. 2000 Jan 15; 8(1):e4. Larson PS, Reisner A, Morassutti DJ, Abdulhadi B, Harpring JE. PMID: 16906700.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    118. Emergency magnetic resonance imaging of cervical spinal cord injuries: clinical correlation and prognosis. Neurosurgery. 1999 Oct; 45(4):956-7. Larson PS, Christiano JA, Raque GH, Shields CB. PMID: 10515498.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    119. Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin Cancer Res. 1998 Nov; 4(11):2787-93. Lazar AD, Winter MR, Nogueira CP, Larson PS, Finnemore EM, Dolan RW, Fuleihan N, Chakravarti A, Zietman A, Rosenberg CL. PMID: 9829743.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    120. Visuomotor learning in cerebellar patients. Behav Brain Res. 1996 Nov; 81(1-2):99-113. Timmann D, Shimansky Y, Larson PS, Wunderlich DA, Stelmach GE, Bloedel JR. PMID: 8950006.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    121. Real time operations of the cerebellar cortex. Can J Neurol Sci. 1993 May; 20 Suppl 3:S7-18. Bloedel JR, Bracha V, Larson PS. PMID: 8334594.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells